Adze Biotechnology logo

Adze Biotechnology Funding & Investors

Adze Biotechnology is a pre-clinical stage company that develops oncolytic immunotherapies for the treatment of cancers. It has exclusive licenses to oncolytic immunotherapies developed in the lab of Dr. Michael Barry of Mayo Clinic. The company was founded in 2019 and is based in Coral Gables, Florida.

adzebiotech.com

Total Amount Raised: $6,149,998

Adze Biotechnology Funding Rounds

  • Series A

    $6,149,998

Funding info provided by Diffbot.